Jean-Éric Tarride, who became Director of CHEPA on May 1, 2017, is an Associate Professor in McMaster's Department of Health Research Methods, Evidence, and Impact (HEI) and an investigator in the Programs for Assessment of Technology in Health (PATH) Research Institute, which consists of multiple research programs in economic evaluation and health technology assessment (HTA). He is the faculty director of the Trial & Economic Modeling Methodology Program (TEMMP) at PATH. Tarride is also an Associate Member of the Department of Economics at McMaster, a Faculty Member of the Centre for Evaluation of Medicines (CEM), St. Josephs Healthcare, Hamilton and a member of CHEPA.
He has a PhD in Economics from Concordia University (2004), an M.A. in Labour Economics (Toulouse, 1991) and an Honours B.A. in Econometrics (Toulouse, 1989). Tarride received a 2007 Career Scientist Award from the Ontario Ministry of Health and Long-Term Care (MOHLTC). His primary research interests are in methods for the economic evaluation of health technologies and treatment of uncertainty in health technology assessments. He has authored more than 100 peer-reviewed journal articles related to economic evaluations of healthcare technologies. Tarride has also worked for more than 10 years in the pharmaceutical industry including as Director of Health Economics and Reimbursement at AstraZeneca Canada.
- Methods for the economic evaluation of health technologies
- Treatment of uncertainty in health technology assessments
Lim ME, Worster A, Goeree R, Tarride JE. Simulating an emergency department: the importance of modeling the interactions between physicians and delegates in a discrete event simulation. Medical Decision Making. May 22 2013.(13)59. doi: 10.1186/1472-6947-13-59 (PhD student 's thesis chapter).
McCarron CE, Pullenayegum EM, Thabane L, Goeree R, Tarride JE. The impact of using informative priors in a Bayesian cost-effectiveness analysis: an application of endovascular versus open surgical repair for abdominal aortic aneurysms in high-risk patients. Medical Decision Making. April 2013.33(3):437-50. doi: 10.1177/0272989X12458457. Epub 2012 Oct 9. (PhD student's thesis chapter)
Tarride JE, Burke N, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R. Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res. 2012.4:287-98.
Tarride JE, Bowen J, DeRose G, Blackhouse G, Hopkins R, Novick T, O’Reilly D, Goeree R. Response to a letter to the editor regarding “Cost-effectiveness analysis of elective endovascular repair (EVAR) compared to open surgical repair (OSR) of abdominal aortic aneurysms for patient at a high surgical risk. A one-year patient-level analysis conducted in Ontario, Canada.” Journal of Vascular Surgery, 2009; 49(1): 277-278.
Blackhouse G, Hopkins R, Bowen JM, DeRose G, Novick T, Tarride JE, O’Reilly D, Xie F, Goeree R. A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada. Value in Health, 2009; 12(2): 245-52.
Tarride JE, Lim ME, Bowen JM, McCarron CE, Blackhouse G, Hopkins R, O’Reilly D, Xie F, Goeree R. In search of the evidentiary foundation of published Canadian economic evaluations (2001-06). International Journal of Technology Assessment in Health Care 2009; 25(2): 214-221.
Lim M, O’Reilly D, Tarride JE, Burke N, Ferrusi I, Goeree R. Health technology assessment for radiologists: basic principles and evaluation framework. Journal of the American College of Radiology, 2009; 6(5): 299-306.
Tarride JE, Blackhouse G, Bischof M, McCarron EC, Lim M, Ferrusi I, Xie F, Goeree R. Approaches to economic evaluations of healthcare technologies. Journal of the American College of Radiology, 2009; 6(5): 307-16.
- principles and components of contemporary health technology assessment
- costing methodology for economic evaluations
- techniques of decision analytic modelling